Jacobs Levy Equity Management’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-557,936
| Closed | -$3.33M | – | 1103 |
|
|
2025
Q1 | $3.33M | Sell |
557,936
-364,198
| -39% | -$2.17M | 0.01% | 553 |
|
|
2024
Q4 | $7.08M | Buy |
922,134
+716,271
| +348% | +$5.5M | 0.03% | 360 |
|
|
2024
Q3 | $2.1M | Buy |
205,863
+29,549
| +17% | +$302K | 0.01% | 593 |
|
|
2024
Q2 | $2.62M | Sell |
176,314
-328,231
| -65% | -$4.87M | 0.01% | 561 |
|
|
2024
Q1 | $6.88M | Sell |
504,545
-30,116
| -6% | -$411K | 0.03% | 369 |
|
|
2023
Q4 | $5.85M | Buy |
534,661
+74,949
| +16% | +$821K | 0.03% | 399 |
|
|
2023
Q3 | $5.03M | Sell |
459,712
-30,668
| -6% | -$336K | 0.03% | 377 |
|
|
2023
Q2 | $6.49M | Sell |
490,380
-24,545
| -5% | -$325K | 0.04% | 339 |
|
|
2023
Q1 | $7.01M | Buy |
514,925
+11,395
| +2% | +$155K | 0.04% | 339 |
|
|
2022
Q4 | $9.83M | Buy |
503,530
+37,205
| +8% | +$727K | 0.07% | 282 |
|
|
2022
Q3 | $8.88M | Buy |
+466,325
| New | +$8.88M | 0.07% | 276 |
|
|
2022
Q2 | – | Sell |
-48,545
| Closed | -$1.56M | – | 1041 |
|
|
2022
Q1 | $1.56M | Buy |
48,545
+2,994
| +7% | +$96.3K | 0.01% | 674 |
|
|
2021
Q4 | $2.12M | Buy |
+45,551
| New | +$2.12M | 0.01% | 609 |
|
|
2021
Q3 | – | Sell |
-26,205
| Closed | -$672K | – | 1083 |
|
|
2021
Q2 | $672K | Buy |
+26,205
| New | +$672K | ﹤0.01% | 815 |
|